These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 32785257)

  • 1. A new method for estimating HIV incidence from a single cross-sectional survey.
    Fellows IE; Shiraishi RW; Cherutich P; Achia T; Young PW; Kim AA
    PLoS One; 2020; 15(8):e0237221. PubMed ID: 32785257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short Communication: Assessing Estimates of HIV Incidence with a Recent Infection Testing Algorithm That Includes Viral Load Testing and Exposure to Antiretroviral Therapy.
    Kim AA; Rehle T
    AIDS Res Hum Retroviruses; 2018 Oct; 34(10):863-866. PubMed ID: 29926735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual behaviours, HIV testing, and the proportion of men at risk of transmitting and acquiring HIV in London, UK, 2000-13: a serial cross-sectional study.
    Aghaizu A; Wayal S; Nardone A; Parsons V; Copas A; Mercey D; Hart G; Gilson R; Johnson AM
    Lancet HIV; 2016 Sep; 3(9):e431-e440. PubMed ID: 27562744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.
    Huerga H; Shiferie F; Grebe E; Giuliani R; Farhat JB; Van-Cutsem G; Cohen K
    BMC Infect Dis; 2017 Sep; 17(1):653. PubMed ID: 28969607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIITE: HIV-1 incidence and infection time estimator.
    Park SY; Love TMT; Kapoor S; Lee HY
    Bioinformatics; 2018 Jun; 34(12):2046-2052. PubMed ID: 29438560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the BED capture enzyme immunoassay to estimate HIV incidence among adults in three countries in sub-Saharan Africa.
    Kim AA; McDougal JS; Hargrove J; Rehle T; Pillay-Van Wyk V; Puren A; Ekra A; Borget-Alloue MY; Adje-Toure C; Abdullahi AS; Odawo L; Marum L; Parekh BS
    AIDS Res Hum Retroviruses; 2010 Oct; 26(10):1051-61. PubMed ID: 20849299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating HIV Incidence Using a Cross-Sectional Survey: Comparison of Three Approaches in a Hyperendemic Setting, Ndhiwa Subcounty, Kenya, 2012.
    Blaizot S; Kim AA; Zeh C; Riche B; Maman D; De Cock KM; Etard JF; Ecochard R
    AIDS Res Hum Retroviruses; 2017 May; 33(5):472-481. PubMed ID: 27824254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of HIV-1 Incidence Using a Testing History-Based Method; Analysis From the Population-Based HIV Impact Assessment Survey Data in 12 African Countries.
    Gurley SA; Stupp PW; Fellows IE; Parekh BS; Young PW; Shiraishi RW; Sullivan PS; Voetsch AC
    J Acquir Immune Defic Syndr; 2023 Mar; 92(3):189-196. PubMed ID: 36730779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance and usability of mPIMA™ HIV 1/2 viral load test in point of care settings in Kenya.
    Bwana P; Ageng'o J; Danda J; Mbugua J; Handa A; Mwau M
    J Clin Virol; 2019 Dec; 121():104202. PubMed ID: 31715524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cascade of HIV care and population viral suppression in a high-burden region of Kenya.
    Maman D; Zeh C; Mukui I; Kirubi B; Masson S; Opolo V; Szumilin E; Riche B; Etard JF
    AIDS; 2015 Jul; 29(12):1557-65. PubMed ID: 26244395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study.
    Solomon SS; Mehta SH; McFall AM; Srikrishnan AK; Saravanan S; Laeyendecker O; Balakrishnan P; Celentano DD; Solomon S; Lucas GM
    Lancet HIV; 2016 Apr; 3(4):e183-90. PubMed ID: 27036994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV incidence in western Kenya during scale-up of antiretroviral therapy and voluntary medical male circumcision: a population-based cohort analysis.
    Borgdorff MW; Kwaro D; Obor D; Otieno G; Kamire V; Odongo F; Owuor P; Muthusi J; Mills LA; Joseph R; Schmitz ME; Young PW; Zielinski-Gutierrez E; De Cock KM
    Lancet HIV; 2018 May; 5(5):e241-e249. PubMed ID: 29650451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya.
    Maina EK; Mureithi H; Adan AA; Muriuki J; Lwembe RM; Bukusi EA
    Int J Infect Dis; 2020 Aug; 97():151-158. PubMed ID: 32497804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi).
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Goemaere E; Wanjala S; Masiku C; Szumilin E; Etard JF; Maman D; Davies MA
    Glob Health Action; 2019; 12(1):1679472. PubMed ID: 31679482
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries.
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Wanjala S; Masiku C; Szumilin E; Etard JF; Davies MA; Maman D
    PLoS One; 2018; 13(11):e0207656. PubMed ID: 30475865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the use of adjusted cross-sectional estimators of HIV incidence.
    Wang R; Lagakos SW
    J Acquir Immune Defic Syndr; 2009 Dec; 52(5):538-47. PubMed ID: 19881357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size methods for estimating HIV incidence from cross-sectional surveys.
    Konikoff J; Brookmeyer R
    Biometrics; 2015 Dec; 71(4):1121-9. PubMed ID: 26302040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the statistical accuracy of biomarker assays for HIV incidence.
    Brookmeyer R
    J Acquir Immune Defic Syndr; 2010 Aug; 54(4):406-14. PubMed ID: 20436353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Getting more from heterogeneous HIV-1 surveillance data in a high immigration country: estimation of incidence and undiagnosed population size using multiple biomarkers.
    Giardina F; Romero-Severson EO; Axelsson M; Svedhem V; Leitner T; Britton T; Albert J
    Int J Epidemiol; 2019 Dec; 48(6):1795-1803. PubMed ID: 31074780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.